CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Cincinnati, Ohio, United States and 125 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Cincinnati, Ohio, United States and 50 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Cincinnati, Ohio, United States of America and 50 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Cincinnati, Ohio, United States and 66 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Cincinnati, Ohio, United States and 215 other locations
This trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combi...
Phase 2
Cincinnati, Ohio, United States and 75 other locations
regimens in participants with relapsed or refractory mantle cell lymphoma (MCL) previously treated either with or without a Bruton's tyrosin...
Phase 2
Cincinnati, Ohio, United States and 102 other locations
This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...
Phase 3
Cincinnati, Ohio, United States of America and 226 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Cincinnati, Ohio, United States of America and 29 other locations
and cyclophosphamide alone in a lymphodepletion regimen prior to ALLO-501A CAR T therapy in adults with relapsed or refractory large B-cell lymphoma...
Phase 2
Cincinnati, Ohio, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal